Impactive Capital LP Charles River Laboratories International, Inc. Transaction History
Impactive Capital LP
- $2.19 Billion
- Q1 2025
A detailed history of Impactive Capital LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Impactive Capital LP holds 1,211,538 shares of CRL stock, worth $183 Million. This represents 8.34% of its overall portfolio holdings.
Number of Shares
1,211,538
Previous 1,202,339
0.77%
Holding current value
$183 Million
Previous $222 Million
17.84%
% of portfolio
8.34%
Previous 9.54%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$922 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$768 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$647 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$361 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$295 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.68B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...